NovoCare and the Rise of Direct-to-Consumer Pha...

By Rene Pretorius

March 14, 2025

NovoCare Pharmacy has launched a direct-to-consumer pharmaceutical access program for Wegovy (semaglutide), offering the medication at $499 per month for uninsured...
Cost Savings and Impact of Comprehensive Medication Management in Healthcare
South Africa’s Innovative Strategy for Cervical Cancer Prevention
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
Effective Management of Diabetes in Arab Region: Insights and Strategies
Healthcare for Older Adults in Türkiye: A Call for Reform
Strengthening Immunisation in the Eastern Mediterranean: WHO Launches Regiona...
Healthier Future Initiatives for the Eastern Mediterranean Region
Olympus and Proximie Forge Partnership to Transform Digital Healthcare
NICE Rejects Donanemab for NHS Use Due to Cost Concerns
Telemedicine Growth in the MENA Region: A Digital Healthcare Revolution
Innovative Pricing and Payment Models for Health Technologies